| Implanted vascular access device related deep vein thrombosis in oncology patients: a prospective cohort study A Suleman, V Jarvis, A Hadziomerovic, M Carrier, S McDiarmid Thrombosis Research 177, 117-121, 2019 | 15 | 2019 |
| The use of virtual care in patients with hematologic malignancies: a scoping review A Suleman, A Vijenthira, A Berlin, A Prica, D Rodin Current Oncology 29 (2), 892-900, 2022 | 9 | 2022 |
| Disseminated cryptococcal infection in a patient with treatment-naïve chronic lymphocytic leukemia (CLL) A Suleman, R Padmore, C Faught, J Cowan IDCases 17, e00566, 2019 | 9 | 2019 |
| Evaluation of a personalized subcutaneous immunoglobulin treatment program for neurological patients A Suleman, L Theoret, P Bourque, E Pringle, DW Cameron, J Cowan Canadian Journal of Neurological Sciences 46 (1), 38-43, 2019 | 8 | 2019 |
| Methotrexate, cytarabine, thiotepa and rituximab (MATRix) chemoimmunotherapy for primary central nervous system lymphoma: a Toronto experience A Suleman, J Liu, LK Hicks, AK Drori, M Crump, R Kridel, A Prica, ... Haematologica 108 (4), 1186, 2023 | 4 | 2023 |
| Hypermetabolic lymphadenopathy on positron emission tomography scan following COVID‐19 vaccination: A mimicker of disease progression in Hodgkin lymphoma A Suleman, A Bilbily, M Cheung, L Chodirker Ejhaem 2 (3), 678, 2021 | 4 | 2021 |
| A retrospective analysis of catheter-related upper extremity deep vein thrombosis in peripherally inserted catheters with and without a dermatotomy A Suleman, S McDiarmid Journal of the Association for Vascular Access 22 (4), 178-181, 2017 | 4 | 2017 |
| Evaluation of the protein gap for detection of abnormal serum gammaglobulin level: an imperfect predictor A Suleman, DW Cameron, V Corrales-Medina, C McCudden, J Cowan Clinical Chemistry and Laboratory Medicine (CCLM) 59 (5), 869-874, 2021 | 3 | 2021 |
| Indolent lymphoma care delivery and outcomes during the COVID‐19 pandemic in Ontario, Canada IY Gong, A Prica, Z Ante, A Calzavara, MK Krzyzanowska, S Singh, ... British Journal of Haematology 204 (3), 805-814, 2024 | 2 | 2024 |
| Virtual care during the COVID-19 pandemic for patients with hematologic malignancies: a single-institution experience A Suleman, A Vijenthira, ZA Liu, T Truong, A Berlin, A Prica, D Rodin JCO Oncology Practice 19 (5), e672-e682, 2023 | 2 | 2023 |
| Outcomes of patients with indolent lymphoma treated with bendamustine plus rituximab compared to rituximab plus CVP or CHOP chemoimmunotherapy in Ontario A Suleman, SJ Aktar, Z Ante, N Liu, KKW Chan, MC Cheung, A Prica British Journal of Haematology 202 (6), 1104-1118, 2023 | 1 | 2023 |
| Virtual Care during the COVID-19 Pandemic Among Patients with Hematologic Malignancies-a Princess Margaret Cancer Centre Experience A Suleman, A Vijenthira, T Trong, A Berlin, A Prica, D Rodin Blood 138, 838, 2021 | 1 | 2021 |
| The Risk of Venous Thromboembolism in Primary Central Nervous System Lymphoma: A Systematic Review and Meta Analysis A Suleman, R Wine, M Carrier, LK Hicks Research and Practice in Thrombosis and Haemostasis, 102507, 2024 | | 2024 |
| Assessing the Impact of Marginalization on Survival for Patients Undergoing Allogeneic Stem Cell Transplant in Ontario, Canada A Suleman, S Podolsky, N Liu, KKW Chan, S Arya, L Hicks, MC Cheung, ... Blood 142, 5175, 2023 | | 2023 |
| Outcomes of Transplant-Eligible and Transplant-Ineligible Patients with Mantle Cell Lymphoma in Ontario, Canada A Suleman, Z Ante, N Liu, M Crump, KKW Chan, MC Cheung, A Prica Blood 142, 1665, 2023 | | 2023 |
| An International Multicenter Study of Primary Vitreoretinal Lymphoma from the Australasian Lymphoma Alliance and Collaborators C Tang, L Zhang, A Suleman, KL Lewis, D Quinn, M Poon, W Hann, ... Blood 142, 3132, 2023 | | 2023 |
| Assessing the Impact of Marginalization on Survival for Patients Undergoing Autologous Stem Cell Transplant in Ontario, Canada A Suleman, S Podolsky, N Liu, KKW Chan, S Arya, L Hicks, MC Cheung, ... Blood 142, 2389, 2023 | | 2023 |
| PB0947 The Risk of Venous Thromboembolism in Primary Central Nervous System Lymphoma: A Systematic Review A Suleman, R Wine, M Carrier, L Hicks Research and Practice in Thrombosis and Haemostasis 7, 2023 | | 2023 |
| EBV-positive diffuse large B-cell lymphoma following alemtuzumab therapy for T-cell prolymphocytic leukemia A Suleman, H Tsui, Z Ghorab, PW Lam, L Mozessohn Annals of Hematology 102 (2), 471-472, 2023 | | 2023 |
| An Unusual Mimicker of Tumor Lysis Syndrome with Hepatic and Renal Failure A Suleman, N Champion, Y Lee Canadian Journal of General Internal Medicine 16 (4), 53-58, 2021 | | 2021 |
